Afuco™ Anti-Human S100A9 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-S100A9 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies against S100A9 are useful in treating, preventing or alleviating the symptoms of an inflammatory disorder of the lung in a subject in need thereof. The inflammatory lung disorder may be, for example, inflammation in the lung associated with COPD, asthma, IPF, MS, RA or SLE.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-525CL |
| Pricing | Inquiry |
| Host | Human |
| Target | S100A9 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage |
|